Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect on neutrophil migration and antimicrobial functions by the Bruton's tyrosine kinase inhibitors tolebrutinib, evobrutinib and fenebrutinib.
De Bondt M, Renders J, de Prado PP, Berghmans N, Pörtner N, Vanbrabant L, de Oliveira VLS, Duran G, Baeten P, Broux B, Gouwy M, Matthys P, Hellings N, Struyf S. De Bondt M, et al. Among authors: vanbrabant l. J Leukoc Biol. 2024 Jul 8:qiae160. doi: 10.1093/jleuko/qiae160. Online ahead of print. J Leukoc Biol. 2024. PMID: 38976501
Matrix Metalloproteinase-9-Generated COOH-, but Not NH2-Terminal Fragments of Serum Amyloid A1 Retain Potentiating Activity in Neutrophil Migration to CXCL8, With Loss of Direct Chemotactic and Cytokine-Inducing Capacity.
Gouwy M, De Buck M, Abouelasrar Salama S, Vandooren J, Knoops S, Pörtner N, Vanbrabant L, Berghmans N, Opdenakker G, Proost P, Van Damme J, Struyf S. Gouwy M, et al. Among authors: vanbrabant l. Front Immunol. 2018 Jun 4;9:1081. doi: 10.3389/fimmu.2018.01081. eCollection 2018. Front Immunol. 2018. PMID: 29915572 Free PMC article.
Method Matters: Effect of Purification Technology on Neutrophil Phenotype and Function.
Blanter M, Cambier S, De Bondt M, Vanbrabant L, Pörtner N, Abouelasrar Salama S, Metzemaekers M, Marques PE, Struyf S, Proost P, Gouwy M. Blanter M, et al. Among authors: vanbrabant l. Front Immunol. 2022 Feb 10;13:820058. doi: 10.3389/fimmu.2022.820058. eCollection 2022. Front Immunol. 2022. PMID: 35222394 Free PMC article.
Induction of Chemokines by Hepatitis C Virus Proteins: Synergy of the Core Protein with Interleukin-1β and Interferon-γ in Liver Bystander Cells.
Abouelasrar Salama S, Gouwy M, De Zutter A, Pörtner N, Vanbrabant L, Berghmans N, De Buck M, Struyf S, Van Damme J. Abouelasrar Salama S, et al. Among authors: vanbrabant l. J Interferon Cytokine Res. 2020 Apr;40(4):195-206. doi: 10.1089/jir.2019.0115. Epub 2020 Feb 7. J Interferon Cytokine Res. 2020. PMID: 32031878
The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors.
De Zutter A, Crijns H, Berghmans N, García-Caballero M, Vanbrabant L, Pörtner N, Vanheule V, Verscheure P, Siddiquei MM, Abu El-Asrar AM, Carmeliet P, Van Wielendaele P, De Meester I, Van Damme J, Proost P, Struyf S. De Zutter A, et al. Among authors: vanbrabant l. Cancers (Basel). 2021 Oct 12;13(20):5090. doi: 10.3390/cancers13205090. Cancers (Basel). 2021. PMID: 34680238 Free PMC article.
Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity.
Dillemans L, Yu K, De Zutter A, Noppen S, Gouwy M, Berghmans N, Verhallen L, De Bondt M, Vanbrabant L, Brusselmans S, Martens E, Schols D, Verschueren P, Rosenkilde MM, Marques PE, Struyf S, Proost P. Dillemans L, et al. Among authors: vanbrabant l. Cell Commun Signal. 2024 Feb 2;22(1):94. doi: 10.1186/s12964-023-01453-1. Cell Commun Signal. 2024. PMID: 38308278 Free PMC article.
Phenotypical and Functional Characterization of Neutrophils in Two Pyrin-Associated Auto-inflammatory Diseases.
Malengier-Devlies B, Metzemaekers M, Gouwy M, Van Nieuwenhove E, Betrains A, Cockx M, Vanbrabant L, Pörtner N, Vercauteren J, De Somer L, Struyf S, Vanderschueren S, De Langhe E, Proost P, Matthys P, Wouters C. Malengier-Devlies B, et al. Among authors: vanbrabant l. J Clin Immunol. 2021 Jul;41(5):1072-1084. doi: 10.1007/s10875-021-01008-4. Epub 2021 Mar 5. J Clin Immunol. 2021. PMID: 33666778
25 results